India Hemostat Market, By Product Form (Mechanical, Flowable), By Product Base (Gelatin, Cellulose), By Application (Surgeries, Trauma Cases), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) - Size, Share, Outlook, and Opportunity Analysis,

India Hemostat Market, By Product Form (Mechanical, Flowable), By Product Base (Gelatin, Cellulose), By Application (Surgeries, Trauma Cases), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Hemostats, also referred to as hemostatic clamp, arterial forceps or pean are surgical tools used in surgical procedures to control bleeding. The hemostats were designed to clamp blood vessels of small size to manage blood flow in hemorrhagic cases. These devices are also used to grasp and secure superficial fascia during wound closure surgical procedures. The hemostats, with hinges and rings, are visibly similar to scissors. These instruments have a locking mechanism known as rachet that is used for clamping wherein the jaws of locking forceps come together, which helps in sealing the opening of the blood vessels. In many cases, the hemostats can be used to hold the subcutaneous tissues on the edges of the wound, while the tissue forceps are applied to the other edge to retract and gain better exposure to the wound site.
Restraints of the India Hemostat Market
Lack of awareness among healthcare practitioners regarding latest hemostat products is expected to hinder growth of India hemostat market.
Key features of the study:
This report provides in-depth analysis of the India hemostat market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the India hemostat market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Ethicon Inc., Aegis Lifesciences. Eucare Pharmaceuticals (P) Ltd., Baxter International, Axio Biosolutions Private Limited, and Mil Laboratories.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The India hemostat market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
India Hemostat Market, By Product Form:
Mechanical
Flowable
India Hemostat Market, By Product Base:
Gelatin
Cellulose
India Hemostat Market, By Application:
Surgeries
Trauma Cases
India Hemostat Market, By End User:
Hospitals
Ambulatory Surgical Centers
Clinics
Company Profiles
Ethicon Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Aegis Lifesciences
Eucare Pharmaceuticals (P) Ltd.
Baxter International
Axio BioSolutions Private Limited
Mil Laboratories
“*” marked represents similar segmentation in other categories in the respective section.